Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the …
… risks of severe COVID-19 outcomes in people with immune-mediated inflammatory diseases
… population-based electronic health record data linked to a new, unique national hospital …
… population-based electronic health record data linked to a new, unique national hospital …
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
… -CoV-2 infection and its outcomes. In this Review, we summarise data on … risk for SARS-CoV-2
infection and severe COVID-19 in patients with immune-mediated inflammatory diseases …
infection and severe COVID-19 in patients with immune-mediated inflammatory diseases …
Direct and indirect impact of COVID-19 for patients with immune-mediated inflammatory diseases: a retrospective cohort study
V Belleudi, AC Rosa, FR Poggi, A Armuzzi… - Journal of clinical …, 2021 - mdpi.com
… immune-mediated inflammatory diseases (IMIDs). Objective: Our aim was to investigate the
impact of COVID-19 in terms of risks … factor for poor outcomes in patients with COVID-19 [2], …
impact of COVID-19 in terms of risks … factor for poor outcomes in patients with COVID-19 [2], …
Risk of severe COVID-19 outcomes among patients with immune-mediated inflammatory diseases or malignancies: a retrospective analysis of real-world data in the …
… ) severity. The aim of this study was to describe … COVID-19 and immune-mediated inflammatory
diseases (IMIDs) or malignancies and evaluate their risk of developing severe COVID-19…
diseases (IMIDs) or malignancies and evaluate their risk of developing severe COVID-19…
… between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19
… patients with immune-mediated inflammatory diseases (IMIDs) and COVID-19 were reported
… monotherapy was associated with a lower risk of adverse COVID-19 outcomes compared …
… monotherapy was associated with a lower risk of adverse COVID-19 outcomes compared …
[PDF][PDF] More on Covid-19 in Immune-Mediated Inflammatory Diseases.
F Briggs, MA Gianfrancesco, MF George - 2020 - scholar.dominican.edu
… of biologics was not associated with worse Covid-19 outcomes in patients with … immune-mediated
inflammatory disease who are treated with biologics are at increased risk for Covid-19 …
inflammatory disease who are treated with biologics are at increased risk for Covid-19 …
COVID-19 hospitalizations, intensive care unit stays, ventilation, and death among patients with immune-mediated inflammatory diseases compared to controls
… of hospitalizations for COVID-19 and their outcomes between IMID and non-IMID patients. …
In summary, we found that the risk of severe COVID-19 requiring hospitalization is increased …
In summary, we found that the risk of severe COVID-19 requiring hospitalization is increased …
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies–a Danish population-based cohort study
M Attauabi, JB Seidelin, OK Felding, MD Wewer… - Journal of …, 2021 - Elsevier
… the association between COVID-19, frequent rheumatological, … outcomes included
development of COVID-19, COVID-19-… In the univariate analysis of the risk of COVID-19-related …
development of COVID-19, COVID-19-… In the univariate analysis of the risk of COVID-19-related …
Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak
J Veenstra, CR Buechler, G Robinson… - Journal of the American …, 2020 - Elsevier
… outcomes from COVID-19 among those treated for IMIDs, including those with potentially more
severe … an attempt to reduce risk of COVID-19 and related illness, although consideration …
severe … an attempt to reduce risk of COVID-19 and related illness, although consideration …
[HTML][HTML] Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a …
Q Wei, PJ Mease, M Chiorean, L Iles-Shih, WF Matos… - Medrxiv, 2023 - ncbi.nlm.nih.gov
… Although patients with IMIDs are at higher risk for severe COVID-19, this research suggests
that their comorbidities are greater risk factors, rather than the IMIDs themselves, or the use …
that their comorbidities are greater risk factors, rather than the IMIDs themselves, or the use …